Researchers at the Spanish National Cancer Research Center (CNIO) propose a new treatment for brain metastases that respond ...

BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class ...

A new treatment has been proposed for immunotherapy-resistant brain metastases, with a biomarker identified that can predict ...

A Cleveland Clinic-led research collaboration between Timothy Chan, MD, Ph.D., Chair of Cleveland Clinic's Global Center for ...

An oncologist tells PEOPLE about the innovative cancer treatment that extended the former president’s life as he celebrates ...

In a follow-up study, researchers compared cancer immunotherapy in mice, using either single or double immune responses. And ...

Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) ...

Nouscom has also exclusively out-licensed VAC-85135, an off-the-shelf immunotherapy developed under a multi-project agreement, which is currently under evaluation in a Phase 1 trial for the treatment ...

A phase 2/3 non-inferiority study compared de-escalation strategies to standard chemoradiation in patients with human ...

Thanks to early detection through widespread screening and dramatic breakthroughs in immunotherapy and other cancer ...

North America Cancer Immunotherapy Market is expanding rapidly due to expanding approval of immunotherapeutic drugs for the treatment of increasing incidences of cancer and increasing investments in ...